Follow
Md Ashraf-Uz-Zaman
Md Ashraf-Uz-Zaman
Post-doctoral Associate, Baylor College of Medicine, Houston, TX
Verified email at bcm.edu - Homepage
Title
Cited by
Cited by
Year
Emerging importance of tyrosine kinase inhibitors against cancer: quo vadis to cure?
RK Mongre, CB Mishra, AK Shukla, A Prakash, S Jung, ...
International Journal of Molecular Sciences 22 (21), 11659, 2021
242021
Assessing the current state of lung cancer chemoprevention: a comprehensive overview
M Ashraf-Uz-Zaman, A Bhalerao, CM Mikelis, L Cucullo, NA German
Cancers 12 (5), 1265, 2020
172020
Comparative pharmacological studies of Abelmoschuse sculentus Linn. Fruits and seeds
SJ Shammi, R Islam, RM Ashraf-Uz-Zaman, B Alam
Global Journal of Pharmacology 8 (1), 98-106, 2014
152014
Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer
M Ashraf-Uz-Zaman, S Shahi, R Akwii, MS Sajib, MJ Farshbaf, RR Kallem, ...
European journal of medicinal chemistry 209, 112866, 2021
92021
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity
M Ashraf-Uz-Zaman, MS Sajib, L Cucullo, CM Mikelis, NA German
Bioorganic & medicinal chemistry letters 28 (23-24), 3652-3657, 2018
92018
In vivo evaluation of the pharmacological activities of Syzygium samarangense (Blume) Merr. & LM Perry, Adv
R Majumder, NE Hasnat, MAU Zaman, MB Alam
Biol. Res 8 (3), 107-115, 2014
52014
Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus
M Ashraf-Uz-Zaman, X Li, Y Yao, CB Mishra, BK Moku, Y Song
Journal of Medicinal Chemistry 66 (15), 10746-10760, 2023
42023
Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease
M Ashraf-Uz-Zaman, TK Chua, X Li, Y Yao, BK Moku, CB Mishra, ...
ACS Infectious Diseases 10 (2), 715-731, 2024
32024
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
M Ashraf-Uz-Zaman, G Ji, D Tidwell, L Yin, S Thakolwiboon, J Pan, ...
ACS chemical neuroscience 13 (2), 217-228, 2022
32022
Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis
N Kumar, RK Mongre, CB Mishra, R Srivastava, A Kumar, R Khatoon, ...
Frontiers in Microbiology, 896, 2022
12022
Discovery, Structure–Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein–Protein Interactions between AF9/ENL and AF4 or DOT1L
X Li, X Wu, S Nie, J Zhao, Y Yao, F Wu, CB Mishra, M Ashraf-Uz-Zaman, ...
Cancers 15 (21), 5283, 2023
2023
Discovery of novel compound promotes neurogenesis by activation of mTOR signaling
M Ashraf-Uz-Zaman, B Vaidya, T Abbruscato, N German
The FASEB Journal 34 (S1), 1-1, 2020
2020
Discovery and structure‐activity relationship study of novel series of mono‐amine transporter inhibitors for the treatment of neurodegenerative diseases
M Ashraf-Uz-Zaman, G Ji, K Alvina, MS Sajib, C Mikelis, M Avila, ...
The FASEB Journal 34 (S1), 1-1, 2020
2020
Novel diphenylbutylpiperidine analogs to treat lung cancer
MAU Zaman, MS Sajib, C Mikelis, N German
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019
2019
Selective Expression of 2-AG (2-Arachidonoyl Glycerol) Pathway in Mammary Gland Tissues.
B Gudenkauf, K Gandhi, N German, AU Zaman, E Dick, ...
REPRODUCTIVE SCIENCES 26, 342A-342A, 2019
2019
Optimization of penfluridol for use in anticancer therapy
MAU Zaman, MS Sajib, C Mikelis, N German
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–16